These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 26140469)

  • 1. Impact of IL-1 inhibition on fatigue associated with autoinflammatory syndromes.
    Yadlapati S; Efthimiou P
    Mod Rheumatol; 2016; 26(1):3-8. PubMed ID: 26140469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Canakinumab for the treatment of cryopyrin-associated periodic syndromes.
    Walsh GM
    Drugs Today (Barc); 2009 Oct; 45(10):731-5. PubMed ID: 20069137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel Mutation in the Pyrin Domain of the NOD-like Receptor Family Pyrin Domain Containing Protein 3 in Muckle-Wells Syndrome.
    Hu J; Zhu Y; Zhang JZ; Zhang RG; Li HM
    Chin Med J (Engl); 2017 Mar; 130(5):586-593. PubMed ID: 28229991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological treatment options for cryopyrin-associated periodic syndromes.
    Landmann EC; Walker UA
    Expert Rev Clin Pharmacol; 2017 Aug; 10(8):855-864. PubMed ID: 28586272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current treatment recommendations and considerations for cryopyrin-associated periodic syndrome.
    Koné-Paut I; Galeotti C
    Expert Rev Clin Immunol; 2015; 11(10):1083-92. PubMed ID: 26312542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Mutation negative" familial cold autoinflammatory syndrome (FCAS) in an 8-year-old boy: clinical course and functional studies.
    Hedrich CM; Bruck N; Paul D; Hahn G; Gahr M; Rösen-Wolff A
    Rheumatol Int; 2012 Sep; 32(9):2629-36. PubMed ID: 21833523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early canakinumab therapy for the sensorineural deafness in a family with Muckle-Wells syndrome due to a novel mutation of NLRP3 gene.
    Iida Y; Wakiguchi H; Okazaki F; Nakamura T; Yasudo H; Kubo M; Sugahara K; Yamashita H; Suehiro Y; Okayama N; Hashimoto K; Iwamoto N; Kawakami A; Aoki Y; Takada H; Ohga S; Hasegawa S
    Clin Rheumatol; 2019 Mar; 38(3):943-948. PubMed ID: 30338413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CAPS--pathogenesis, presentation and treatment of an autoinflammatory disease.
    Kuemmerle-Deschner JB
    Semin Immunopathol; 2015 Jul; 37(4):377-85. PubMed ID: 25963520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cryopyrin-associated periodic syndromes: diagnosis and management.
    Miyamae T
    Paediatr Drugs; 2012 Apr; 14(2):109-17. PubMed ID: 22335455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis of cryopyrin-associated periodic syndrome: challenges, recommendations and emerging concepts.
    Sarrabay G; Grandemange S; Touitou I
    Expert Rev Clin Immunol; 2015; 11(7):827-35. PubMed ID: 25979514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C3 glomerulopathy in NLRP12-related autoinflammatory disorder: case-based review.
    Başaran Ö; Uncu N; Çakar N; Turanlı ET; Kiremitci S; Aydın F; Bayrakcı US
    Rheumatol Int; 2018 Aug; 38(8):1571-1576. PubMed ID: 29951964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cryopyrin-associated periodic syndromes].
    Quartier P; Rodrigues F; Georgin-Lavialle S
    Rev Med Interne; 2018 Apr; 39(4):287-296. PubMed ID: 29111302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NLRP3 E311K mutation in a large family with Muckle-Wells syndrome--description of a heterogeneous phenotype and response to treatment.
    Kuemmerle-Deschner JB; Lohse P; Koetter I; Dannecker GE; Reess F; Ummenhofer K; Koch S; Tzaribachev N; Bialkowski A; Benseler SM
    Arthritis Res Ther; 2011; 13(6):R196. PubMed ID: 22146561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel knock-in mouse model of cryopyrin-associated periodic syndromes with development of amyloidosis: Therapeutic efficacy of proton pump inhibitors.
    Bertoni A; Carta S; Baldovini C; Penco F; Balza E; Borghini S; Di Duca M; Ognio E; Signori A; Nozza P; Schena F; Castellani P; Pastorino C; Perrone C; Obici L; Martini A; Ceccherini I; Gattorno M; Rubartelli A; Chiesa S
    J Allergy Clin Immunol; 2020 Jan; 145(1):368-378.e13. PubMed ID: 31194989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cryopyrin-associated periodic syndrome.
    Giat E; Lidar M
    Isr Med Assoc J; 2014 Oct; 16(10):659-61. PubMed ID: 25438464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rare Clinical Case of Cryopyrin-associated Periodic Syndrome Presented with Ankylosing Spondylitis: A Case Report.
    Zayaeva AA; Sokolova LV; Shaduro DV; Petrov AV; Kulanthaivel S; Kaliberdenko VB
    Curr Rheumatol Rev; 2022; 18(4):373-379. PubMed ID: 34784874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [CAPS: cryopyrin-associated periodic syndrome].
    Saito MK
    Nihon Rinsho Meneki Gakkai Kaishi; 2011; 34(5):369-77. PubMed ID: 22041424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [An approach to the patients with cryopyrin-associated periodic syndrome (CAPS) : a new biologic response modifier, canakinumab].
    Yokota S; Kikuchi M; Nozawa T; Kizawa T; Kanetaka T; Miyamae T; Mori MA; Nishikomori R; Takata H; Heike T; Hara T; Imagawa T
    Nihon Rinsho Meneki Gakkai Kaishi; 2012; 35(1):23-9. PubMed ID: 22374439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pathophysiological mechanisms underlying cryopyrin-associated periodic syndromes: genetic and molecular basis and the inflammasome].
    Aróstegui JI
    Med Clin (Barc); 2011 Jan; 136 Suppl 1():22-8. PubMed ID: 21596183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current status of understanding the pathogenesis and management of patients with NOMID/CINCA.
    Goldbach-Mansky R
    Curr Rheumatol Rep; 2011 Apr; 13(2):123-31. PubMed ID: 21538043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.